| Literature DB >> 27121005 |
Sabrina Riccardi1, Sebastian Bergling1, Frederic Sigoillot2, Martin Beibel1, Annick Werner1, Juliet Leighton-Davies1, Judith Knehr1, Tewis Bouwmeester1, Christian N Parker1, Guglielmo Roma1, Bernd Kinzel3.
Abstract
BACKGROUND: Hearing loss is the most common sensory defect afflicting several hundred million people worldwide. In most cases, regardless of the original cause, hearing loss is related to the degeneration and death of hair cells and their associated spiral ganglion neurons. Despite this knowledge, relatively few studies have reported regeneration of the auditory system. Significant gaps remain in our understanding of the molecular mechanisms underpinning auditory function, including the factors required for sensory cell regeneration. Recently, the identification of transcriptional activators and repressors of hair cell fate has been augmented by the discovery of microRNAs (miRNAs) associated with hearing loss. As miRNAs are central players of differentiation and cell fate, identification of miRNAs and their gene targets may reveal new pathways for hair cell regeneration, thereby providing new avenues for the treatment of hearing loss.Entities:
Keywords: Hearing loss; MiR-210; Next generation sequencing; Transdifferentiation
Mesh:
Substances:
Year: 2016 PMID: 27121005 PMCID: PMC4848794 DOI: 10.1186/s12864-016-2620-7
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1MicroRNAs differentially expressed during UB/OC-1 differentiation. Heat map representing color-coded expression levels of differentially expressed microRNAs (up- or down-regulated > 2-fold, FDR adjusted p-value < 0.01) in UB/OC-1 at precursor stage (33 °C) and 24 h after induction of differentiation (39 °C, no interferon). MicroRNAs are ranked by fold change. Colors range from bright pink (low expression) to dark red (high expression, around 40’000 reads per million). Expression of 50 miRNAs was enhanced and expression of 49 miRNAs was repressed during early stages of differentiation
Differentially expressed miRNAs with high expression at precursor stage (ranked by FDR) selected for further analysis
| Mature microRNA | Mean read count 33C | Mean RPM 33C | Mean read count 39C | Mean RPM 39C | log2ratio | FDR |
|---|---|---|---|---|---|---|
| mmu-miR-92a-1-5p | 13060 | 11962.26 | 1109 | 960.10 | −3.64 | 7.81E–90 |
| mmu-miR-155-3p | 891 | 812.58 | 87 | 75.06 | −3.44 | 3.67E–59 |
| mmu-miR-147-3p | 5616 | 5189.40 | 1393 | 1241.44 | −2.06 | 6.53E–34 |
| mmu-miR-152-5p | 3649 | 3319.82 | 900 | 761.91 | −2.12 | 2.93E–33 |
| mmu-miR-210-5p | 2652 | 2437.48 | 654 | 572.17 | −2.09 | 4.41E–32 |
| mmu-miR-222-5p | 1469 | 1346.34 | 368 | 326.79 | −2.04 | 1.69E–29 |
| mmu-miR-148a-5p | 372 | 343.95 | 87 | 75.31 | −2.19 | 6.69E–23 |
| mmu-miR-147-5p | 75 | 71.04 | 4 | 3.83 | −4.21 | 1.66E–17 |
Fig. 2Inhibition of miR-210 induces Pou4f3 hair cell marker expression in UB/OC-1 cells. LNAs against various miRNAs were transfected in UB/OC-1 at 33 °C and expression of the hair cell marker Pou4f3 was analyzed by RT-PCR. RT-PCR for GAPDH was used as loading control. Cochlear tissue was used as positive control
Fig. 3Adenovirus mediated miR-210 expression in organ of Corti explants. a Organ of Corti explant transduced with Adenovirus expressing EGFP (EGFP-Ad5), transduced cells are identified by green fluorescence. b Organ of Corti explant transduced with either EGFP-Ad5 (control) or Adenovirus expressing miR-210 (miR210-Ad5). Scale bars: 50 μm. c Cell count of Myosin 7a-positive cells per 100 um2. MiR210-Ad5 transduced organ of Corti explants were compared to EGFP-Ad5 transduced explants, all from wildtype mice
Fig. 4Lineage tracing of Sox2-positive supporting cells after miR-210 overexpression in organ of Corti explants. a Lineage tracing: scheme showing individual mouse lines with modified Sox2 and Rosa26 gene loci for CreERT2 and conditional EGFP expression, respectively. EGFP expression is activated after crossing of both mouse lines and Tamoxifen injection leading to Sox2-Cre-mediated excision of a floxed Stop-cassette which facilitates constitutive EGFP expression in Sox2 expressing cells and cells derived thereof (Sox2 lineage). b Organ of Corti explants of Sox2CreERT2/R26EGFP double transgenic offspring 4 days after Tamoxifen administration. c Organ of Corti explants of Sox2CreERT2/R26EGFP double transgenic offspring 4 days after Tamoxifen administration followed by mir210-Ad5 transduction
Putative miR-210 targets identified by integrative analysis
| Class | Gene ID (mouse) | Gene symbol (mouse) | Reported in the literature as (MetaBase) | Computationally inferred for (TargetScan) | Not in Wang et al. or He et al. | In Wang et al. (2014) | In He et al. (2012) |
|---|---|---|---|---|---|---|---|
| 1 | 72168 | Aifm3 | Present | Mouse and Human |
| FALSE | FALSE |
| 1 | 12043 | Bcl2 | Present | Mouse and Human | FALSE |
| FALSE |
| 1 | 18033 | Nfkb1 | Present | Mouse and Human |
| FALSE | FALSE |
| 1 | 12176 | Bnip3 | Present | Mouse and Human |
| FALSE | FALSE |
| 1 | 20423 | Shh | Present | Mouse and Human |
| FALSE | FALSE |
| 1 | 20852 | Stat6 | Present | Mouse and Human |
| FALSE | FALSE |
| 1 | 21416 | Tcf7l2 | Present | Mouse and Human |
| FALSE | FALSE |
| 2 | 56336 | B4galt5 | Probably present | Mouse and Human | FALSE |
| FALSE |
| 2 | 66383 | Iscu | Probably present | Mouse and Human | FALSE |
| FALSE |
| 2 | 12064 | Bdnf | Probably present | Mouse and Human | FALSE |
| FALSE |
| 2 | 53417 | Hif3a | Probably present | Mouse and Human |
|
|
|
| 2 | 13638 | Efna3 | Probably present | Mouse and Human |
|
|
|
| 2 | 17992 | Ndufa4 | Probably present | Mouse and Human | FALSE |
| FALSE |
| 3 | 333433 | Gpd1l | Not likely present | Mouse and Human | FALSE |
|
|
| 3 | 381022 | Kmt2d | Not likely present | Mouse and Human | FALSE |
| FALSE |
| 3 | 22661 | Zfp148 | Not likely present | Mouse and Human |
| FALSE | FALSE |
| 3 | 68041 | Mid1ip1 | Not likely present | Mouse and Human | FALSE |
| FALSE |
| 3 | 231207 | Cpeb2 | Not likely present | Mouse and Human |
| FALSE | FALSE |
| 3 | 170729 | Scrt1 | Not likely present | Mouse and Human |
| FALSE | FALSE |
| 3 | 240057 | Syngap1 | Not likely present | Mouse and Human |
| FALSE |
|
| 3 | 74287 | Kcmf1 | Not likely present | Mouse and Human | FALSE |
| FALSE |
| 3 | 18013 | Neurod2 | Not likely present | Mouse and Human |
| FALSE | FALSE |
| 4 | 207393 | Elfn2 | Absent | Mouse and Human | FALSE |
| FALSE |
| 4 | 17258 | Mef2a | Absent | Mouse and Human |
| FALSE | FALSE |
| 4 | 74244 | Atg7 | Absent | Mouse and Human | FALSE |
| FALSE |
| 5 | 69662 | 2310061I04Rik | Absent | Mouse or Human | FALSE |
| FALSE |
| 5 | 225791 | Zadh2 | Absent | Mouse or Human | FALSE |
| FALSE |
| 5 | 52132 | Ccdc97 | Absent | Mouse or Human | FALSE |
| FALSE |
| 5 | 210573 | Tmem151b | Absent | Mouse or Human |
|
|
|
| 5 | 20362 | Sept8 | Absent | Mouse or Human |
| FALSE | FALSE |
| 5 | 433940 | Fam222a | Absent | Mouse or Human |
| FALSE | FALSE |
| 5 | 320717 | Pptc7 | Absent | Mouse or Human | FALSE |
| FALSE |
| 5 | 545554 | Ankrd34a | Absent | Mouse or Human |
| FALSE | FALSE |
| 5 | 11515 | Adcy9 | Absent | Mouse or Human |
| FALSE | FALSE |
| 5 | 102247 | Agpat6 | Absent | Mouse or Human |
| FALSE | FALSE |
Genes are displayed in five different classes based on the nature of the supporting evidence (literature-verified versus computational prediction). Literature-verified miRNA/mRNA interactions retrieved from MetaBase were annotated according to the ‘trust’ of the source into “Present”, “Probably present”, “Not likely present”, or “Absent” (e.g. if not available). Computational inferred interactions identified by TargetScan were classified in two different groups, based on whether targets were predicted for the two species analyzed (“Mouse and Human”) or only one (“Mouse or Human”). Predicted targets were compared to previous reports and identical findings annotated as “true” or “false”
Fig. 5Pull-down of miR-210 target RNAs. Immunoprecipitation of RISC after miR-210 overexpression using a MirTrap approach followed by qRT-PCR of isolated mRNA species. Y axes represent fold enrichment versus scrambled control
MiR-210 targets identified by MirTrap
| Gene ID | Gene symbol | Description |
|---|---|---|
| 11479 | Acvr1b | activin A receptor, type 1B |
|
|
|
|
| 108699 | Chn1 | chimerin 1 |
| 211922 | Dennd6a | DENN/MADD domain containing 6A |
| 14357 | Dtx1 | deltex 1 homolog (Drosophila) |
|
|
|
|
| 14782 | Gsr | glutathione reductase |
| 15245 | Hhip | Hedgehog-interacting protein |
| 15394 | Hoxa1 | homeobox A1 |
|
|
|
|
|
|
|
|
| 216858 | Kctd11 | potassium channel tetramerisation domain containing 11 |
|
|
|
|
|
|
|
|
| 244058 | Rgma | repulsive guidance molecule family member A |
| 104001 | Rtn1 | reticulon 1 |
| 67956 | Setd8 | SET domain containing (lysine methyltransferase) 8 |
| 67582 | Slc25a26 | solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 26 |
|
|
|
|
| 21416 | Tcf7l2 | transcription factor 7 like 2, T cell specific, HMG box |
|
|
|
|
| 56338 | Txnip | thioredoxin interacting protein |
| 213742 | Xist | inactive X specific transcripts |
| 21769 | Zfand3 | zinc finger, AN1-type domain 3 |
List of mRNAs with more than 2-fold enrichment after miR-210 MirTrap. MiR-210 targets also identified by integrative in silico analysis (Table 2) are in bold